← Leaderboards
Adam N. Goldfarb
University Of Virginia
$16,754,744
Attributed
$17,149,405
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,149,405 · 13
By mechanism
R01$16,200,351 · 9
R56$490,710 · 2
R41$246,084 · 1
R29$212,260 · 1
Top collaborators
- Angelo D'Alessandro1 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Norbert Leitinger$10,025,679
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsProgenitorCellsRegulationErythroidTranscription FactorIn VivoProductionErythrocytesAnemiaErythropoiesisMolecularErythropoietinSignal TransductionBone MarrowAffectDissectionProgramsResponseIronComplexDeprivationInflammationChronic Disease
Grant awards (49)
The role of ferroptosis in red cell aging in vivo and in vitro$789,323
R01 · FY2025 · HL
Nqo2 in Primaquine-Induced Hemolysis of G6PD-deficient RBCs$716,208
R01 · FY2025 · HL · contact PI
α-Synuclein Regulation of the Erythroid Iron Restriction Response$225,000
R56 · FY2024 · DK · contact PI
Targeting Dyrk1a to Promote Donor-independent Platelet Production$699,189
R01 · FY2023 · HL · contact PI
Dissection and Manipulation of the Cellular Response to Iron Restriction$477,832
R01 · FY2023 · DK · contact PI
Targeting Dyrk1a to Promote Donor-independent Platelet Production$699,189
R01 · FY2022 · HL · contact PI
Dissection and Manipulation of the Cellular Response to Iron Restriction$477,832
R01 · FY2022 · DK · contact PI
Targeting Dyrk1a to Promote Donor-independent Platelet Production$699,189
R01 · FY2021 · HL · contact PI
Dissection and Manipulation of the Cellular Response to Iron Restriction$477,832
R01 · FY2021 · DK · contact PI
Dissection and Manipulation of the Cellular Response to Iron Restriction$40,269
R01 · FY2021 · DK · contact PI
Targeting Dyrk1a to Promote Donor-independent Platelet Production$714,564
R01 · FY2020 · HL · contact PI
Dissection and Manipulation of the Cellular Response to Iron Restriction$546,864
R01 · FY2020 · DK · contact PI
Dissection and Manipulation of the Cellular Response to Iron Restriction$28,763
R01 · FY2020 · DK · contact PI
Dissection and Manipulation of the Cellular Response to Iron Restriction$477,832
R01 · FY2019 · DK · contact PI
Controlling an Ontogenic Masterswitch to Maximize Thrombopoiesis$532,884
R01 · FY2018 · HL · contact PI
Validation of Aconitase-Isocitrate Pathway as a Target for Anemia Treatment$237,000
R01 · FY2018 · DK · contact PI
Controlling an Ontogenic Masterswitch to Maximize Thrombopoiesis$43,344
R01 · FY2018 · HL · contact PI
Controlling an Ontogenic Masterswitch to Maximize Thrombopoiesis$445,926
R01 · FY2017 · HL · contact PI
Dissection and Manipulation of the Cellular Response to Iron Restriction$343,650
R01 · FY2017 · DK · contact PI
Validation of Aconitase-Isocitrate Pathway as a Target for Anemia Treatment$237,000
R01 · FY2017 · DK · contact PI
Controlling an Ontogenic Masterswitch to Maximize Thrombopoiesis$445,926
R01 · FY2016 · HL · contact PI
Dissection and Manipulation of the Cellular Response to Iron Restriction$343,650
R01 · FY2016 · DK · contact PI
Validation of Aconitase-Isocitrate Pathway as a Target for Anemia Treatment$237,000
R01 · FY2016 · DK · contact PI
Controlling an Ontogenic Masterswitch to Maximize Thrombopoiesis$460,426
R01 · FY2015 · HL · contact PI
Dissection and Manipulation of the Cellular Response to Iron Restriction$343,650
R01 · FY2015 · DK · contact PI
Dissection and Manipulation of the Cellular Response to Iron Restriction$343,650
R01 · FY2014 · DK · contact PI
Characterization of a Novel Erythropoietin Signaling Pathway$294,248
R01 · FY2013 · DK · contact PI
Characterization of a Novel Erythropoietin Signaling Pathway$360,940
R01 · FY2012 · DK · contact PI
Preclinical Development of a New Drug for Treating Anemia of Chronic Inflammation$246,084
R41 · FY2012 · AG · contact PI
Iron Deficiency: Molecular and Cellular Consequences$314,904
R01 · FY2011 · DK · contact PI
Characterization of a Novel Erythropoietin Signaling Pathway$304,920
R01 · FY2011 · DK · contact PI
Characterization of a Novel Erythropoietin Signaling Pathway$56,020
R01 · FY2011 · DK · contact PI
Iron Deficiency: Molecular and Cellular Consequences$318,104
R01 · FY2010 · DK · contact PI
Characterization of a Novel Erythropoietin Signaling Pathway$308,000
R01 · FY2010 · DK · contact PI
Iron Deficiency: Molecular and Cellular Consequences$321,335
R01 · FY2009 · DK · contact PI
Iron Deficiency: Molecular and Cellular Consequences$321,352
R01 · FY2008 · DK · contact PI
Involvement of RUNX1 in Megakaryocytic Differentiation$265,710
R56 · FY2008 · CA · contact PI
Involvement of RUNX1 in Megakaryocytic Differentiation$252,012
R01 · FY2007 · CA · contact PI
Involvement of RUNX1 in Megakaryocytic Differentiation$289,405
R01 · FY2006 · CA · contact PI
Regulatory Pathways In Megakaryocyte Differentiation$257,249
R01 · FY2006 · CA · contact PI
Involvement of RUNX1 in Megakaryocytic Differentiation$296,370
R01 · FY2005 · CA
Regulatory Pathways In Megakaryocyte Differentiation$263,440
R01 · FY2005 · CA
Involvement of RUNX1 in Megakaryocytic Differentiation$296,370
R01 · FY2004 · CA
Regulatory Pathways In Megakaryocyte Differentiation$263,440
R01 · FY2004 · CA
Involvement of RUNX1 in Megakaryocytic Differentiation$296,370
R01 · FY2003 · CA
Regulatory Pathways In Megakaryocyte Differentiation$263,440
R01 · FY2003 · CA
Regulatory Pathways In Megakaryocyte Differentiation$263,440
R01 · FY2002 · CA
DETAILED ANALYSIS OF SCL/TAL DIMERIZATION WITH E PROTEIN$107,819
R29 · FY2001 · CA
DETAILED ANALYSIS OF SCL/TAL DIMERIZATION WITH E PROTEIN$104,441
R29 · FY2000 · CA